TNF Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
TNFA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
855 N. Wolfe Street, Suite 601, Baltimore, MD

There are no Buy or Sell transactions made by insiders since 11/5/2023

TNF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul Rivard Chief Legal Officer $444K Aug 24, 2023
PharmaCyte Biotech, Inc. 10%+ Owner May 23, 2024
Stephen Friscia Director Jun 13, 2024
Jude Uzonwanne Director Jun 7, 2023
Christopher C. Schreiber Director Jun 7, 2023
Craig Eagle Director Jun 7, 2023
Adam Kaplin Chief Scientific Officer Jun 7, 2023
Billy Joe White Director Jun 7, 2023
Joshua Silverman Director Jun 7, 2023
Mitchell Glass Director Apr 8, 2024
Christopher Chapman President, Chief Med. Officer, Director Jun 7, 2023

Recent Insider Transactions by Companies or Individuals for TNF Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.